Quality of Life in Men Undergoing Robotic Assisted Laparoscopic Radical Prostatectomy Versus Radical Retropubic Prostatectomy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01173952 |
Recruitment Status
: Unknown
Verified June 2010 by Samsung Medical Center.
Recruitment status was: Not yet recruiting
First Posted
: August 2, 2010
Last Update Posted
: August 2, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Prostatic Neoplasms Quality of Life |
Preoperatively, enrolled patients will complete questionnaires called EPIC that will ask about urinary, sexual, bowel and hormonal function
At 1, 3,6,9 and 12 months after surgery, pateints will complete the questionnaires again.
All will be enrolled at Samsung Medical Center
Study Type : | Observational |
Estimated Enrollment : | 350 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Prospective Evaluation of Quality of Life in Men Undergoing Robotic Assisted Laparoscopic Radical Prostatectomy Vs. Radical Retropubic Prostatectomy |
Study Start Date : | August 2010 |
Estimated Primary Completion Date : | December 2013 |
Estimated Study Completion Date : | January 2014 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Pathologic diagnosis of prostate adenocarcinoma
- Clinical stage: AJCC (VI) stage T1-T2 N0M0
- Primary treatment at Samsung Medical Center for prostate cancer using: radical retropubic prostatectomy, robotic prostatectomy
Exclusion Criteria:
- Clinical Stage: T3, T4, nodal or distant metastasis
- All kind of neoadjuvant, concurrent and adjuvant treatment
- poor health forced a patient into dropout

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01173952
Contact: Sung Won Lee, M.D.& Ph.D. | 82-2-3410-3552 | drswlee@skku.edu | |
Contact: Deok Hyun Han, M.D.& Ph.D. | 82-2-3410-6431 | deokhyun.han@samsung.com |
Study Chair: | Sung Won Lee, M.D.& Ph.D. | Department of Urology Samsung Medical Center |
Responsible Party: | Sung Won Lee, M.D.& Ph.D./Professor, Samsung Medical Center, Sungkyunkwan University School of Medicine, Department of Urology Samsung Medical Center, Sungkyunkwan University School of Medicine |
ClinicalTrials.gov Identifier: | NCT01173952 History of Changes |
Other Study ID Numbers: |
2010-06-026 |
First Posted: | August 2, 2010 Key Record Dates |
Last Update Posted: | August 2, 2010 |
Last Verified: | June 2010 |
Additional relevant MeSH terms:
Prostatic Neoplasms Genital Neoplasms, Male Urogenital Neoplasms Neoplasms by Site |
Neoplasms Genital Diseases, Male Prostatic Diseases |